Zwitterionic structures: from physicochemical properties toward computer-aided drug designs

被引:25
作者
Yang, Zhiwei [1 ,2 ]
Li, Qinyi [1 ]
Yang, Gang [1 ]
机构
[1] Southwest Univ, Coll Resources & Environm, Chongqing 400715, Peoples R China
[2] Jiamusi Univ, Sch Basic Med Sci, Jiamusi 154007, Peoples R China
基金
中国国家自然科学基金;
关键词
bioavailability; computer-aided drug design; physicochemical property; protein-ligand interaction; zwitterionic structures; INFLUENZA-VIRUS NEURAMINIDASE; MEDICINE SALACIA-RETICULATA; SULFONIUM SULFATE STRUCTURE; SIALIC-ACID ANALOGS; GABA-A-RECEPTOR; MOLECULAR-DYNAMICS; ACTIVE-SITE; FREE-ENERGY; ENHANCED BIOAVAILABILITY; OSELTAMIVIR RESISTANCE;
D O I
10.4155/fmc-2016-0176
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Zwitterions, used widely in chemical, biological and medicinal fields, show distinct physicochemical properties relative to ordinary ampholytes, which largely decide their bioavailability and biological activities. In the present manuscript, these properties are discussed in order to facilitate our understanding of zwitterionic structures, followed by various examples of zwitterionic drugs and the critical role these properties play. We specifically focus our discussions on neuraminidase inhibitors (NAIs), which are used in the treatment and prevention of influenza, covering their computer-assisted design, transformation to zwitterionic isomers and interaction mechanisms of NAIs with proteins. The discovery and development of NAIs provide useful insights that may assist in the exploration of new zwitterionic drugs.
引用
收藏
页码:2245 / 2262
页数:18
相关论文
共 129 条
[1]   Remarkable loop flexibility in avian influenza N1 and its implications for antiviral drug design [J].
Amaro, Rommie E. ;
Minh, David D. L. ;
Cheng, Lily S. ;
Lindstrom, William M., Jr. ;
Olson, Arthur J. ;
Lin, Jung-Hsin ;
Li, Wilfred W. ;
McCammon, J. Andrew .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (25) :7764-+
[2]  
[Anonymous], 1995, ENCY PHARM TECHNOLOG
[3]   On the lower susceptibility of oseltamivir to influenza neuraminidase subtype N1 than those in N2 and N9 [J].
Aruksakunwong, Ornjira ;
Malaisree, Maturos ;
Decha, Panita ;
Sompornpisut, Pornthep ;
Parasuk, Vudhichai ;
Pianwanit, Somsak ;
Hannongbua, Supot .
BIOPHYSICAL JOURNAL, 2007, 92 (03) :798-807
[4]   Hydrophobic benzoic acids as inhibitors of influenza neuraminidase [J].
Atigadda, VR ;
Brouillette, WJ ;
Duarte, F ;
Babu, YS ;
Bantia, S ;
Chand, P ;
Chu, NM ;
Montgomery, JA ;
Walsh, DA ;
Sudbeck, E ;
Finley, J ;
Air, GM ;
Luo, M ;
Laver, GW .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) :2487-2497
[5]   BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design [J].
Babu, YS ;
Chand, P ;
Bantia, S ;
Kotian, P ;
Dehghani, A ;
El-Kattan, Y ;
Lin, TH ;
Hutchison, TL ;
Elliott, AJ ;
Parker, CD ;
Ananth, SL ;
Horn, LL ;
Laver, GW ;
Montgomery, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) :3482-3486
[6]   Classification of water molecules in protein binding sites [J].
Barillari, Caterina ;
Taylor, Justine ;
Viner, Russell ;
Essex, Jonathan W. .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (09) :2577-2587
[7]   RECEPTOR CLASSES AND THE TRANSMITTER-GATED ION CHANNELS [J].
BARNARD, EA .
TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (10) :368-374
[8]   Antithyroid Drugs and their Analogues Protect Against Peroxynitrite-Mediated Protein Tyrosine Nitration - A Mechanistic Study [J].
Bhabak, Krishna P. ;
Mugesh, Govindasamy .
CHEMISTRY-A EUROPEAN JOURNAL, 2010, 16 (04) :1175-1185
[9]   Theoretical and experimental exploration of the lipophilicity of zwitterionic drugs in the 1,2-dichloroethane/water system [J].
Bouchard, G ;
Pagliara, A ;
Carrupt, PA ;
Testa, B ;
Gobry, V ;
Girault, HH .
PHARMACEUTICAL RESEARCH, 2002, 19 (08) :1150-1159
[10]   Molecular recognition and docking algorithms [J].
Brooijmans, N ;
Kuntz, ID .
ANNUAL REVIEW OF BIOPHYSICS AND BIOMOLECULAR STRUCTURE, 2003, 32 :335-373